From DCAT Value Chain Insights (VCI)
Actavis plc has named Jonathon Kellerman as executive vice president, global chief compliance officer. Mr. Kellerman is a member of the Actavis Executive Leadership Team (ELT) and will report directly to Brent Saunders, CEO and president. He will also be a member of the Actavis and Allergan pre-integration planning team as well as integration activities following the close of Actavis' pending $66 billion acquisition of Allergan, which is expected to close in the second quarter of 2015.
Mr. Kellerman joins Actavis from PwC, where he was a partner in PwC's Pharmaceutical and Life Sciences Advisory practice, responsible for helping lead the firm's Governance, Risk & Compliance practice, including a global team of over 100 diverse professionals. He brings extensive experience in compliance and sales and marketing performance improvement, including global anti-bribery/anti-corruption program assessment, design and implementation work; building and implementing effective global compliance programs; managing fraud investigations and remediation activities; re-engineering processes supporting key commercial and R&D business activities and compliance controls; and re-designing how companies engage healthcare professionals. He has also led major "rapid response" organizational and business process improvement initiatives across multiple business and support functions. Earlier in his career, Mr. Kellerman worked in Healthcare Consulting for Zelenkofske Axelrod and in Research for Blank Rome.
Thank you for reading DCAT Value Chain Insights (VCI), an information resource from the
Drug, Chemical & Associated Technologies Association (DCAT).
Learn more and sign up to receive a complimentary subscription